Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial

NCT06005662 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT06005662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06005662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Withdrawn
Start date
April 30, 2027
Completion date
July 31, 2028
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder